Drug profile · INN
procyclidine hydrochloride
KEMADRIN
procyclidine hydrochloride (KEMADRIN) is a muscarinic acetylcholine receptor m1 antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — procyclidine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
procyclidine hydrochloride (KEMADRIN) is a muscarinic acetylcholine receptor m1 antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M1 antagonist
Primary target: Muscarinic acetylcholine receptor M1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is procyclidine hydrochloride?
procyclidine hydrochloride (KEMADRIN) is a muscarinic acetylcholine receptor m1 antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for procyclidine hydrochloride?
KEMADRIN is a marketed brand name for procyclidine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of procyclidine hydrochloride?
procyclidine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.